Safety Monitoring of Mpox Vaccines in Adults Aged 18-64 Years during the 2022 Mpox Outbreak in the U.S.

Data Availability

The study protocol was publicly posted as referenced in the manuscript before data analyses, and related documents can be made available where needed by contacting the corresponding author. De-identified participant data will not be shared without approval from the data partners.